| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $10.8M | -14.9% |
| Cost of Revenue | $4.0M | +2.0% |
| Gross Profit | $6.8M | -22.5% |
| R&D Expense | $4.6M | -30.0% |
| SG&A Expense | $17.0M | -11.7% |
| Operating Income | -$17.8M | +15.8% |
| Interest Expense | $1.7M | -76.2% |
| Pre-tax Income | -$25.5M | +9.0% |
| Income Tax | $0 | +100.0% |
| Net Income | -$25.5M | +8.7% |
| EPS (Basic) | -$17.02 | -415.8% |
| EPS (Diluted) | -$17.02 | -415.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $0 | — |
| Current Assets | $9.6M | -25.2% |
| Total Assets | $21.1M | +6.2% |
| Current Liabilities | $8.8M | +122.7% |
| Long-term Debt | $2.3M | +58.6% |
| Total Liabilities | $11.2M | +101.0% |
| Stockholders' Equity | $9.9M | -30.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$13.4M | +13.3% |
| Capital Expenditures | $177K | -37.9% |
| Investing Cash Flow | -$177K | +37.9% |
| Financing Cash Flow | $9.6M | -39.0% |
| Free Cash Flow | -$13.6M | +13.8% |